{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:15:28Z","timestamp":1784578528234,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T00:00:00Z","timestamp":1669507200000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K06712"],"award-info":[{"award-number":["JP21K06712"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lfs.2021.120150","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T06:45:56Z","timestamp":1636958756000},"page":"120150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats"],"prefix":"10.1016","volume":"288","author":[{"given":"Tomohiro","family":"Shigematsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuka","family":"Itoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tsuchimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Ieiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.lfs.2021.120150_bb0005","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.lfs.2021.120150_bb0010","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lfs.2021.120150_bb0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"24","key":"10.1016\/j.lfs.2021.120150_bb0020","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.lfs.2021.120150_bb0025","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/00007890-199712270-00034","article-title":"Mechanism of fibrosis in experimental tacrolimus nephrotoxicity","volume":"64","author":"Shihab","year":"1997","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.lfs.2021.120150_bb0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1159\/000351648","article-title":"Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence","volume":"37","author":"Issa","year":"2013","journal-title":"Am. J. Nephrol."},{"issue":"11","key":"10.1016\/j.lfs.2021.120150_bb0035","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1681\/ASN.2010080793","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"21","author":"Zeisberg","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"19","key":"10.1016\/j.lfs.2021.120150_bb0040","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.lfs.2021.120150_bb0045","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.ki.5001846","article-title":"Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway","volume":"70","author":"Wolf","year":"2006","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.lfs.2021.120150_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12882-019-1399-6","article-title":"Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties","volume":"20","author":"Luo","year":"2019","journal-title":"BMC Nephrol."},{"issue":"10","key":"10.1016\/j.lfs.2021.120150_bb0055","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/labinvest.2015.93","article-title":"Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury","volume":"95","author":"Lim","year":"2015","journal-title":"Lab. Investig."},{"issue":"5","key":"10.1016\/j.lfs.2021.120150_bb0060","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.3892\/mmr.2016.5735","article-title":"Mechanism of tacrolimus-induced chronic renal fibrosis following transplantation is regulated by ox-LDL and its receptor, LOX-1","volume":"14","author":"Deng","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.lfs.2021.120150_bb0065","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.transproceed.2006.06.102","article-title":"Comparison of expression of TGF-beta1, its receptors TGFbeta1R-I and TGFbeta1R-II in rat kidneys during chronic nephropathy induced by cyclosporine and tacrolimus","volume":"38","author":"Bing","year":"2006","journal-title":"Transplant. Proc."},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0070","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.TP.0000128837.07640.AE","article-title":"Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin","volume":"78","author":"Ninova","year":"2004","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.lfs.2021.120150_bb0075","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1046\/j.1523-1755.2002.00668.x","article-title":"Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity","volume":"62","author":"Khanna","year":"2002","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1681\/ASN.2005080891","article-title":"Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies","volume":"17","author":"Groningen","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.lfs.2021.120150_bb0090","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1681\/ASN.2008111186","article-title":"The role of the mammalian target of rapamycin (mTOR) in renal disease","volume":"20","author":"Lieberthal","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.lfs.2021.120150_bb0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2016.108","article-title":"Roles of mTOR complexes in the kidney: implications for renal disease and transplantation","volume":"12","author":"Fantus","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2021.120150_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.kint.2019.01.041","article-title":"An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients","volume":"96","author":"Sommerer","year":"2019","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032516","article-title":"Delayed mTOR inhibition with low dose of everolimus reduces TGF\u03b2 expression, attenuates proteinuria and renal damage in the renal mass reduction model","volume":"7","author":"Kurdi\u00e1n","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120150_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxlet.2021.01.020","article-title":"Establishment of an experimental rat model of tacrolimus-induced kidney injury accompanied by interstitial fibrosis","volume":"341","author":"Fu","year":"2021","journal-title":"Toxicol. Lett."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2021.120150_bb0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2012.09.010","article-title":"Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury","volume":"696","author":"Nakagawa","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2021.120150_bb0120","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1681\/ASN.2010090956","article-title":"Suramin inhibits renal fibrosis in chronic kidney disease","volume":"22","author":"Liu","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.TP.0000128612.75163.26","article-title":"Evolution and pathophysiology of renal-transplant glomerulosclerosis","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.lfs.2021.120150_bb0130","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.15040920","article-title":"Long-term immunosuppression management: opportunities and uncertainties","author":"Wojciechowski","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2021.120150_bb0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2021.120150_bb0140","doi-asserted-by":"crossref","first-page":"F142","DOI":"10.1152\/ajprenal.00320.2009","article-title":"Noncanonical TGF-beta pathways, mTORC1 and abl, in renal interstitial fibrogenesis","volume":"298","author":"Wang","year":"2010","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"11","key":"10.1016\/j.lfs.2021.120150_bb0145","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41419-018-1157-x","article-title":"Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury","volume":"9","author":"Qi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.lfs.2021.120150_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00418-008-0452-5","article-title":"The renal cortical interstitium: morphological and functional aspects","volume":"130","author":"Kaissling","year":"2008","journal-title":"Histochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0155","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.kint.2016.08.025","article-title":"Progression of chronic kidney disease: too much cellular talk causes damage","volume":"91","author":"Gewin","year":"2017","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000446336","article-title":"Signaling crosstalk between tubular epithelial cells and interstitial fibroblasts after kidney injury","volume":"2","author":"Tan","year":"2016","journal-title":"Kidney Dis (Basel)"},{"issue":"1","key":"10.1016\/j.lfs.2021.120150_bb0165","first-page":"535","article-title":"Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor","volume":"289","author":"Johnson","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00007890-199508000-00005","article-title":"Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects","volume":"60","author":"Wolf","year":"1995","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.lfs.2021.120150_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5050050","article-title":"Tacrolimus modulates TGF-\u03b2 signaling to induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells","volume":"5","author":"Bennett","year":"2016","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.lfs.2021.120150_bb0180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.lfs.2021.120150_bb0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/kisup.2014.7","article-title":"Macrophages promote renal fibrosis through direct and indirect mechanisms","volume":"4","author":"Nikolic-Paterson","year":"2011","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.lfs.2021.120150_bb0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1523-1755.2003.00714.x","article-title":"Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy","volume":"63","author":"Tamada","year":"2003","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2021.120150_bb0195","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.tp.0000252779.56951.bf","article-title":"Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients","volume":"83","author":"Koch","year":"2007","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.lfs.2021.120150_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033626","article-title":"Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2021.120150_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.2018020209","article-title":"The MEK inhibitor trametinib ameliorates kidney fibrosis by suppressing ERK1\/2 and mTORC1 signaling","volume":"30","author":"Andrikopoulos","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.lfs.2021.120150_bb0210","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1681\/ASN.2012050476","article-title":"Rheb\/mTORC1 signaling promotes kidney fibroblast activation and fibrosis","volume":"24","author":"Jiang","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.lfs.2021.120150_bb0215","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.34067\/KID.0003782020","article-title":"mTOR signaling in kidney diseases","volume":"1","author":"Gui","year":"2020","journal-title":"Kidney360"},{"issue":"11","key":"10.1016\/j.lfs.2021.120150_bb0220","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/sj.ki.5000161","article-title":"Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis","volume":"69","author":"Wu","year":"2006","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.lfs.2021.120150_bb0225","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ndt\/gfw443","article-title":"Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies","volume":"33","author":"Mariani","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.lfs.2021.120150_bb0230","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2010.120","article-title":"Renal fibrosis: novel insights into mechanisms and therapeutic targets","volume":"6","author":"Boor","year":"2010","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T10:30:45Z","timestamp":1717237845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521011371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":46,"alternative-id":["S0024320521011371"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120150","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120150"}}